Rakesh Ranjan
Psychiatry · Medina, OHNPI 1073549606
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $322,037 of the $423,495 with a category attached, or 76.0%. 31 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 44.6% of the total. Reporting peaked in 2019 at $113,838 and has fallen 89.1% since, to $12,399 in 2025. Among psychiatry clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,339 payments — averaging $316.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$189K
- Otsuka America Pharmaceutical, Inc.$81K
- Alkermes, Inc.$75K
- AbbVie$66K
- Biogen$5K
- Indivior Inc.$2K
- plus $6K from 25 others
Across 239 payments — averaging $1220.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$97K
- Livanova USA, Inc.$81K
- Vanda Pharmaceuticals Inc.$43K
- Acadia Pharmaceuticals Inc$22K
- Sumitomo Pharma America, Inc.$13K
- E.r. Squibb & Sons, L.L.C.$13K
- plus $22K from 7 others
What the payments were for
- Consulting fees$34,3788%
- Speaking & faculty fees$322,03776%
- Travel & lodging$40,93010%
- Food & beverage$25,2366%
- Education$9070%
- Gifts$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 300 | $188,972 |
| Otsuka America Pharmaceutical, Inc. | 281 | $81,433 |
| Alkermes, Inc. | 187 | $75,184 |
| AbbVie(2 entities) | 195 | $65,518 |
| Biogen | 1 | $4,912 |
| Indivior Inc. | 27 | $1,918 |
| Vanda Pharmaceuticals Inc. | 74 | $1,041 |
| Lundbeck LLC | 69 | $983 |
| Johnson & Johnson | 41 | $691 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 53 | $617 |
| Validus Pharmaceuticals LLC | 12 | $517 |
| Sunovion Pharmaceuticals Inc. | 23 | $475 |
| Supernus Pharmaceuticals, Inc. | 12 | $241 |
| Axsome Therapeutics, Inc. | 8 | $166 |
| E.r. Squibb & Sons, L.L.C. | 17 | $153 |
| Neuronetics, Inc. | 11 | $149 |
| Livanova USA, Inc. | 2 | $63 |
| Noven Therapeutics, LLC | 4 | $61 |
| Bioxcel Therapeutics, Inc. | 2 | $59 |
| Neurocrine Biosciences, Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Bausch Health US, LLC | 2 | $38 |
| Shire North American Group Inc | 2 | $36 |
| Avanir Pharmaceuticals, Inc. | 2 | $32 |
| Jazz Pharmaceuticals Inc. | 2 | $31 |
| Ironshore Pharmaceuticals Inc. | 2 | $29 |
| Eisai Inc. | 1 | $18 |
| Corium, LLC | 1 | $17 |
| Noven Pharmaceuticals, Inc. | 1 | $14 |
| Orexo US, Inc. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$172,107
- AUSTEDO$119,940
- LYBALVI$117,259
- ABILIFY MAINTENA$62,881
- VRAYLAR$62,796
- Austedo XR$46,567
- ARISTADA INITIO$43,027
- UZEDY$15,406
- REXULTI$14,993
- ABILIFY ASIMTUFII$9,777
- SUBLOCADE$1,513
- Equetro$449
- VIIBRYD$200
How this compares
$423,495 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ziprasidone Hcl | 20 | $861 |
| Donepezil Hcl | 13 | $312 |
| Mirtazapine | 11 | $162 |
| Sertraline Hcl | 17 | $68 |
| Bupropion XlBupropion Hcl | 11 | $48 |
| Clonazepam | 17 | $2 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Medina
- Henry NasrallahCincinnati$3.8M
- Fred RomeoColumbus$2.3M
- Amita PatelDayton$2.1M
- Pradeep ManudhaneCanton$1.5M
- Michael SaribalasColumbus$1.2M
- Kevin WareColumbus$1.1M
- Binit ShahCleveland$913K
- Paul KeckCincinnati$739K
- Ali MelhemSteubenville$681K
- Tracey SkaleCincinnati$674K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.